Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the website as revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-02T16:27:32.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    An NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a website transition.
    Difference
    0.3%
    Check dated 2026-10-26T16:42:57.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-19T21:51:17.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-10-13T04:21:17.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The revision label changes from v3.6.6 to v3.7.0, indicating a software version update. This does not modify the study data, navigation, or visible content on the page.
    Difference
    0.0%
    Check dated 2026-09-21T22:48:29.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The history now shows a new revision v3.6.6 replacing v3.6.5, signaling a published update to the page's version.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:32.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.